Literature DB >> 26514427

DCIR negatively regulates CpG-ODN-induced IL-1β and IL-6 production.

Xibao Zhao1, Yaping Shen1, Weiwei Hu2, Junru Chen1, Tian Wu1, Xiaoqiang Sun1, Juan Yu1, Tingting Wu1, Weilin Chen3.   

Abstract

C-type lectin receptors (CLR) are a diverse family of proteins mainly expressed on antigen-presenting cells (APC). As antigen-uptake and signaling receptors, CLR modulate immune responses of APC. The dendritic cell immunoreceptor (DCIR) is a member of CLR and has an immunoreceptor tyrosine based inhibitory motif (ITIM) in cytoplasmic tail, which is believed to play a negative role in cellular responses after antigen exposure. In addition to pathogen recognition, DCIR has been shown to be pivotal in preventing autoimmune disease by controlling dendritic cell proliferation. However, much less is known about the role of DCIR in innate immunity and its crosstalk with the Toll like receptors (TLR) pathway. In this study, we demonstrate that CpG-ODN stimulation can promote DCIR expression in macrophages and DCIR triggering inhibits the production of CpG-ODN-induced proinflammatory cytokines. We further confirm that siRNA-mediated knockdown of DCIR expression enhances CpG-ODN-induced phosphorylation of Erk1/2, JNK1/2 and p38 in macrophages. Collectively, these results indicate that DCIR is a negatively regulator in TLR9-mediated innate immune response.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  C-type lectin receptors (CLR); Dendritic cell immunoreceptor (DCIR); Toll like receptors (TLR)

Mesh:

Substances:

Year:  2015        PMID: 26514427     DOI: 10.1016/j.molimm.2015.10.007

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

1.  C-type lectin receptor DCIR modulates immunity to tuberculosis by sustaining type I interferon signaling in dendritic cells.

Authors:  Anthony Troegeler; Ingrid Mercier; Céline Cougoule; Danilo Pietretti; André Colom; Carine Duval; Thien-Phong Vu Manh; Florence Capilla; Renaud Poincloux; Karine Pingris; Jérôme Nigou; Jörg Rademann; Marc Dalod; Frank A W Verreck; Talal Al Saati; Geanncarlo Lugo-Villarino; Bernd Lepenies; Denis Hudrisier; Olivier Neyrolles
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

Review 2.  New Targets for Antiviral Therapy: Inhibitory Receptors and Immune Checkpoints on Myeloid Cells.

Authors:  Yanni Liu; Paul Nicklin; Yuan He
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

3.  CpG-ODN-mediated TLR9 innate immune signalling and calcium dyshomeostasis converge on the NFκB inhibitory protein IκBβ to drive IL1α and IL1β expression.

Authors:  Robyn De Dios; Leanna Nguyen; Sankar Ghosh; Sarah McKenna; Clyde J Wright
Journal:  Immunology       Date:  2020-03-18       Impact factor: 7.397

4.  Teuvincenone F Suppresses LPS-Induced Inflammation and NLRP3 Inflammasome Activation by Attenuating NEMO Ubiquitination.

Authors:  Xibao Zhao; Debing Pu; Zizhao Zhao; Huihui Zhu; Hongrui Li; Yaping Shen; Xingjie Zhang; Ruihan Zhang; Jianzhong Shen; Weilie Xiao; Weilin Chen
Journal:  Front Pharmacol       Date:  2017-08-23       Impact factor: 5.810

Review 5.  C-Type Lectin Receptors in Antiviral Immunity and Viral Escape.

Authors:  Marta Bermejo-Jambrina; Julia Eder; Leanne C Helgers; Nina Hertoghs; Bernadien M Nijmeijer; Melissa Stunnenberg; Teunis B H Geijtenbeek
Journal:  Front Immunol       Date:  2018-03-26       Impact factor: 7.561

Review 6.  Interactions of Surface Exopolysaccharides From Bifidobacterium and Lactobacillus Within the Intestinal Environment.

Authors:  Nuria Castro-Bravo; Jerry M Wells; Abelardo Margolles; Patricia Ruas-Madiedo
Journal:  Front Microbiol       Date:  2018-10-11       Impact factor: 5.640

7.  Dendritic cell immunoreceptor drives atopic dermatitis by modulating oxidized CaMKII-involved mast cell activation.

Authors:  Xiaoyan Luo; Jingsi Chen; Huan Yang; Xinyue Hu; Martin P Alphonse; Yingchun Shen; Yuko Kawakami; Xiaoying Zhou; Wei Tu; Toshiaki Kawakami; Mei Wan; Nathan K Archer; Hua Wang; Peisong Gao
Journal:  JCI Insight       Date:  2022-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.